Published on : Jun 24, 2016
ALBANY, New York, June 24, 2016 – Market Research Hub has added the report ‘Global Cancer Immunotherapies Market 2016-2020’ to its offerings. The report encapsulates an in-depth understanding of the market for cancer immunotherapies. Both primary and secondary research has been conducted in order to collate this report. The chief dynamics impacting the development of this market such as trends, challenges, drivers, and opportunities have also been included under this research study. The top technological advancements taking place in this market are also presented along with highlighting their impact on the development of the market. The competitive landscape section of the report elaborates on the key players dominant in the market and throws light on their commercial production dates and R&D status.
Cancer immunotherapy refers to the utilization of the immune system for the treatment of cancer. Cancer immunotherapy treatments that are utilized to enhance and harness the innate powers of immune systems in order to fight cancer have emerged as the most favorable treatment options currently. This treatment accompanies great chances of eliminating cancer for longer periods of time. In addition, immunotherapies are characterized by their fewer side effects and can be used for the treatment of various kinds of cancer.
The report begins by presenting the market overview section of the global cancer immunotherapies market. This section elaborates upon the key aspects such as cancer immunotherapies, spending on cancer, reimbursement policies, and economic burden of cancer.
In the next section of the report, the dynamics impacting the growth of the market have been presented. The rising demand for cancer monoclonal antibodies is fuelling the growth of the cancer immunotherapies market. In addition, the rising patient assistance programs are also predicted to augment the development of the market from 2016 to 2020. Furthermore, the promising pipeline for the treatment of a number of cancers will also augment the development of the market. The proliferation of combination and targeted therapies is a key trend seen in the market. On the other hand, top-selling drugs’ patent expiry and the increasing number of side-effects post immunotherapy treatments are the chief challenges that may restrain the growth of the market.
On the basis of type, the report segments the cancer immunotherapies market into immune checkpoint inhibitors, cancer monoclonal antibodies, non-specific immunotherapies, and cancer vaccines. Of these, cancer monoclonal antibodies held the largest share in the market in 2015. This is owing to the rising usage of cancer monoclonal antibodies in a number of therapies such as antibody-directed enzyme prodrug therapy and radio immunotherapy. In addition, monoclonal antibodies are extremely useful in the treatment of cancer owing to the fact that they can be designed for targeting a specific area in a cancerous cell.
Click here to get more info with TOC in a PDF Format: http://www.marketresearchhub.com/enquiry.php?type=S&repid=715922
Next in the report comes the geographical segmentation of the market. Geographically, the report segments the market into the Americas, Asia Pacific (APAC), and Europe, the Middle East, and Africa (EMEA). As stated in the report, the key players dominant in the market are Amgen, Bristol-Myers Squibb, F. Hoffmann-La Roche, GlaxoSmithKline, Merck, and Takeda Pharmaceuticals, among others.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com